|
LMF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.180800E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.70140000000419E-05 |
| Normal-vs-Stage2 |
4.860900E-03 |
| Normal-vs-Stage3 |
1.282980E-01 |
| Normal-vs-Stage4 |
5.438000E-01 |
| Stage1-vs-Stage2 |
5.441000E-01 |
| Stage1-vs-Stage3 |
3.371600E-02 |
| Stage1-vs-Stage4 |
2.422500E-03 |
| Stage2-vs-Stage3 |
5.991700E-02 |
| Stage2-vs-Stage4 |
1.600100E-02 |
| Stage3-vs-Stage4 |
3.964200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.424210E-02 |
| Normal-vs-AfricanAmerican |
5.52299994627248E-09 |
| Normal-vs-Asian |
8.873800E-02 |
| Caucasian-vs-AfricanAmerican |
3.18540000043832E-07 |
| Caucasian-vs-Asian |
1.461970E-01 |
| AfricanAmerican-vs-Asian |
3.608000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.077920E-02 |
| Normal-vs-Female |
2.44479999998992E-05 |
| Male-vs-Female |
2.101800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.572300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.360500E-03 |
| Normal-vs-Age(61-80Yrs) |
5.963000E-03 |
| Normal-vs-Age(81-100Yrs) |
4.029600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.748600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.403400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.772000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.713000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.797800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.235600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.050400E-02 |
| Normal-vs-Grade 2 |
7.443800E-03 |
| Normal-vs-Grade 3 |
8.436400E-04 |
| Normal-vs-Grade 4 |
2.199600E-01 |
| Grade 1-vs-Grade 2 |
2.232800E-01 |
| Grade 1-vs-Grade 3 |
2.863800E-01 |
| Grade 1-vs-Grade 4 |
9.856500E-02 |
| Grade 2-vs-Grade 3 |
5.383600E-01 |
| Grade 2-vs-Grade 4 |
4.576400E-01 |
| Grade 3-vs-Grade 4 |
2.162600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.870600E-01 |
| Normal-vs-ccB subtype |
1.67902000000053E-05 |
| ccA subtype-vs-ccB subtype |
2.22999999999196E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.799200E-04 |
| Normal-vs-N1 |
7.668200E-02 |
| N0-vs-N1 |
7.124600E-01 |
|
|
